By Freddy Sebastian
Shares of medical-technology company Pulmonx gained after it shook up its leadership, bringing back former executives at the helm.
Pulmonx's shares jumped nearly 33% to $2.07 in after-hours trading on Monday.
The company said it re-appointed Glen French as its president and chief executive and Derrick Sung as chief operating officer and chief financial officer, replacing Steve Williamson and Mehul Joshi, respectively, effective Nov. 3.
The company said Williamson and Joshi will serve in advisory capacities through Dec. 1 for a transition and their resignations aren't due to any disagreements with Pulmonx.
Separately, the company said it expects third-quarter revenue at $21.5 million. Analysts surveyed by FactSet expect revenue of $20.8 million.
Pulmonx expects to release quarterly results on Nov. 12.
Write to Freddy Sebastian at freddy.sebastian@wsj.com
(END) Dow Jones Newswires
October 27, 2025 18:39 ET (22:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments